PARTHENOLIDE: SUGGESTED DRUG FOR COVID-19

被引：0
|
作者：
Nemati, M. [1 ]
Pouya, F. Danesh [1 ]
Asl, E. Roshni [1 ]
Rasmi, Y. [1 ,2 ]
机构：
[1] Urmia Univ Med Sci, Dept Biochem, Sch Med, Orumiyeh, Iran
[2] Urmia Univ Med Sci, Cellular & Mol Res Ctr, Orumiyeh, Iran
来源：
INFEKTSIYA I IMMUNITET | 2020年 / 10卷 / 04期
关键词：
Parthenolide; COVID-19; NF-kappa B; ACTIVATION; INHIBITORS;
D O I：
10.15789/2220-7619-PSD-1509
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the 2019 novel coronavirus (2019-nCoV) that causes acute respiratory distress syndrome (ARDS) which is the main reason for patients mortality. One of the effective treatments to reduce the effects of this virus is parthenolide (PN). Parthenolide is a sesquiterpene lactone found in medicinal plants. It can inhibit several pro-inflammatory signaling pathways, in particular the ATPase activity of NLRP3. Based on its ability to suppress inflammatory signal transduction and elevated level of serum IL-1 beta (a surrogate marker for NLRP3 activation) in COVID-19 patients, we suggest that PN could be potentiallyeffective for the treatment of COVID-19.
引用
收藏
页码：789 / 791
页数：3
相关论文
共 50 条
  • [21] A Suggested Role of Human Growth Hormone in Control of the COVID-19 Pandemic
    Elkarow, Mohamed Hamdy
    Hamdy, Amr
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [22] Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
    Arshadi, Arash Keshavarzi
    Webb, Julia
    Salem, Milad
    Cruz, Emmanuel
    Calad-Thomson, Stacie
    Ghadirian, Niloofar
    Collins, Jennifer
    Diez-Cecilia, Elena
    Kelly, Brendan
    Goodarzi, Hani
    Yuan, Jiann Shiun
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2020, 3
  • [23] Drug repurposing for COVID-19: Approaches, challenges and promising candidates
    Ng, Yan Ling
    Salim, Cyrill Kafi
    Chu, Justin Jang Hann
    PHARMACOLOGY & THERAPEUTICS, 2021, 228
  • [24] A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19
    Khataniar, Ankita
    Pathak, Upasana
    Rajkhowa, Sanchaita
    Jha, Anupam Nath
    COVID, 2022, 2 (02): : 148 - 167
  • [25] SELENIUM TO SELENOPROTEINS - ROLE IN COVID-19
    Tomo, Sojit
    Saikiran, Gangam
    Banerjee, Mithu
    Paul, Sushmita
    EXCLI JOURNAL, 2021, 20 : 781 - 791
  • [26] Niclosamide for Covid-19: bridging the gap
    Al-kuraishy, Hayder M.
    Al-Gareeb, Ali I.
    Alzahrani, Khalid J.
    Alexiou, Athanasios
    Batiha, Gaber El-Saber
    MOLECULAR BIOLOGY REPORTS, 2021, 48 (12) : 8195 - 8202
  • [27] Curcumin as a Potential Treatment for COVID-19
    Rattis, Brune A. C.
    Ramos, Simone G.
    Celes, Mara R. N.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Drug Interactions of Psychiatric and COVID-19 Medications
    Mohebbi, Niayesh
    Talebi, Ali
    Moghadamnia, Marjan
    Taloki, Zahra Nazari
    Shakiba, Alia
    BASIC AND CLINICAL NEUROSCIENCE, 2020, 11 (02) : 185 - 200
  • [29] Amantadine as a drug to mitigate the effects of COVID-19
    Aranda Abreu, Gonzalo Emiliano
    Hernandez Aguilar, Maria Elena
    Herrera Covarrubias, Deissy
    Rojas Duran, Fausto
    MEDICAL HYPOTHESES, 2020, 140
  • [30] Plitidepsin: a Repurposed Drug for the Treatment of COVID-19
    Angel Martinez, Miguel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
12345